25 results for “Alzheimer's Disease”. Showing 25 of 39,449.
Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans.
Alzheimer disease in African American individuals is unknown. Identification of disease
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
Alzheimer's disease groups (p<0·001, Alzheimer's disease
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
Alzheimer's disease biomarkers are important for early diagnosis in routine
Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
Alzheimer's disease, and 83 [21%] with Alzheimer's disease
Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's disease.
Alzheimer's disease, 55 controls from the Dominantly Inherited Alzheimer
Vitamin D and the risk of dementia and Alzheimer disease.
Alzheimer disease. One thousand six hundred fifty-eight elderly ambulatory
Novel genes involved in vascular dysfunction of the middle temporal gyrus in Alzheimer's disease: transcriptomics combined with machine learning analysis.
Alzheimer's disease. The middle temporal gyrus region of the brain
Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight.
Alzheimer disease, and APOE was recently shown to affect the disease
Home-Based Gamma Transcranial Alternating Current Stimulation in Patients With Alzheimer Disease: A Randomized Clinical Trial.
Alzheimer Disease Assessment Scale-cognitive subscale (0.93; 95% CI, 0.50-1.36; P = .001), Alzheimer
Plasma Lipids as Biomarkers for Alzheimer's Disease: A Systematic Review.
Alzheimer's disease (AD) is caused by several risk factors
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study.
Alzheimer's disease syndromes (Alzheimer's disease dementia, logopenic variant
The Epidemiology of Alzheimer's Disease Modifiable Risk Factors and Prevention.
Alzheimer's disease prevention. Moreover, Alzheimer's disease is considered
Investigation of Potential Drug Targets for Cholesterol Regulation to Treat Alzheimer's Disease.
Alzheimer's disease. Lowering SREBP2 levels in an Alzheimer's disease
Genetic and epigenetic targets of natural dietary compounds as anti-Alzheimer's agents.
Alzheimer's disease, known as familial Alzheimer's disease (onset
Choroid plexus tumor necrosis factor receptor 1: A new neuroinflammatory piece of the complex Alzheimer's disease puzzle.
Alzheimer's disease, and the consequences this might have on the disease
TREM2 variants in Alzheimer's disease.
Alzheimer's disease. (Funded by Alzheimer's Research UK and others
Oral Health as a Risk Factor for Alzheimer Disease.
diseases and Alzheimer's disease. 4 theories could be distinguished
Blood serum from individuals with Alzheimer's disease alters microglial phagocytosis in vitro.
Alzheimer's disease, but fuels neuroinflammation and accelerates disease progression
[Cholesterol and Alzheimer's disease].
Alzheimer's disease. The E4 allele carrier Alzheimer's disease
Trans-activator of transcription-pre-B-cell leukemia transcription factor 1 alleviates Alzheimer's disease by reducing neuronal insulin resistance and restoring energy homeostasis.
Alzheimer's disease remain limited because of side effects and disease
APOE2 gene therapy reduces amyloid deposition, and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer disease.
Alzheimer disease, and if they do they have a later
APOE2 gene therapy reduces amyloid deposition and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer disease.
Alzheimer disease, and if they do, they have a later
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.
Alzheimer disease. To assess efficacy and adverse events of donanemab
Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials.
Alzheimer's disease pathology, differentiate Alzheimer's disease from other
Donanemab in Early Alzheimer's Disease.
Alzheimer's Disease Assessment Scale (ADAS-Cog13), the Alzheimer's Disease